Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Ward

Showing results (31-40 of 55) with videos related to

Pageof 6
Sort By:
Chirality|January 1, 1997
Synthesis and structural determination of stereoisomers of muscarinic ligands of the (3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicycloalkane typeP H Olesen, P Sauerberg, T G Petersen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
M1 receptor agonist activity is not a requirement for muscarinic antinociceptionM J Sheardown, H E Shannon, M D Swedberg, et al.
The Journal of Clinical Investigation|September 19, 2001
GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorderR A Baiocchi, J S Ward, L Carrodeguas, et al.
Journal of Medicinal Chemistry|June 12, 1992
Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines P Sauerberg, P H Olesen, S Nielsen, et al.
Journal of Medicinal Chemistry|October 30, 1992
Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophoreJ S Ward, L Merritt, V J Klimkowski, et al.
Life Sciences|January 1, 1995
Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogsP Sauerberg, P H Olesen, M J Sheardown, et al.
Journal of Medicinal Chemistry|January 23, 1998
Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activityP Sauerberg, P H Olesen, M J Sheardown, et al.
Neuroreport|December 17, 1998
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned ratsA Fink-Jensen, P Kristensen, H E Shannon, et al.
Journal of Medicinal Chemistry|February 17, 1998
1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonistsJ S Ward, L Merritt, D O Calligaro, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in ratsH E Shannon, J C Hart, F P Bymaster, et al.
Pageof 6

Showing results (31-40 of 55) with videos related to

Sort By:
Pageof 6
Chirality|January 1, 1997
Synthesis and structural determination of stereoisomers of muscarinic ligands of the (3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicycloalkane typeP H Olesen, P Sauerberg, T G Petersen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1997
M1 receptor agonist activity is not a requirement for muscarinic antinociceptionM J Sheardown, H E Shannon, M D Swedberg, et al.
The Journal of Clinical Investigation|September 19, 2001
GM-CSF and IL-2 induce specific cellular immunity and provide protection against Epstein-Barr virus lymphoproliferative disorderR A Baiocchi, J S Ward, L Carrodeguas, et al.
Journal of Medicinal Chemistry|June 12, 1992
Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines P Sauerberg, P H Olesen, S Nielsen, et al.
Journal of Medicinal Chemistry|October 30, 1992
Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophoreJ S Ward, L Merritt, V J Klimkowski, et al.
Life Sciences|January 1, 1995
Muscarinic agonists as analgesics. Antinociceptive activity versus M1 activity: SAR of alkylthio-TZTP's and related 1,2,5-thiadiazole analogsP Sauerberg, P H Olesen, M J Sheardown, et al.
Journal of Medicinal Chemistry|January 23, 1998
Conformationally constrained analogues of the muscarinic agonist 3-(4-(methylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyr idine. Synthesis, receptor affinity, and antinociceptive activityP Sauerberg, P H Olesen, M J Sheardown, et al.
Neuroreport|December 17, 1998
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned ratsA Fink-Jensen, P Kristensen, H E Shannon, et al.
Journal of Medicinal Chemistry|February 17, 1998
1,2,5-Thiadiazole analogues of aceclidine as potent m1 muscarinic agonistsJ S Ward, L Merritt, D O Calligaro, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 20, 1999
Muscarinic receptor agonists, like dopamine receptor antagonist antipsychotics, inhibit conditioned avoidance response in ratsH E Shannon, J C Hart, F P Bymaster, et al.
Pageof 6